KalVista Pharmaceuticals, Inc. (KALV)
26.72
0.00 (0.00%)
USD |
NASDAQ |
May 07, 14:29
KalVista Pharmaceuticals SG&A Expense (TTM) : 191.34M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 119.80M |
| Recursion Pharmaceuticals, Inc. | 121.94M |
| Tango Therapeutics, Inc. | 41.51M |
| BioCryst Pharmaceuticals, Inc. | 266.18M |
| Iovance Biotherapeutics, Inc. | 152.58M |